Introduction Application of artificial intelligence (AI) tools in the healthcare setting gains importance especially in the domain of disease diagnosis. Numerous studies have tried to explore AI in ...

Moroney to scale Tines' "customer zero" strategy and showcase how intelligent workflows at scale drive efficiency, security, and enterprise AI readiness. DUBLIN and BOSTON, Dec. 11, 2025 /PRNewswire/ ...

Moroney to scale Tines' "customer zero" strategy and showcase how intelligent workflows at scale drive efficiency, security, and enterprise AI readiness. The move comes as organizations accelerate AI ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

The Nigerian Shippers’ Council has unveiled the Enterprise Content Management System (ECMS), a sophisticated internal tool designed to eliminate deficiencies, delays that often accompany paper-based ...